首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   148068篇
  免费   9967篇
  国内免费   624篇
耳鼻咽喉   1859篇
儿科学   3813篇
妇产科学   2531篇
基础医学   19511篇
口腔科学   2625篇
临床医学   14790篇
内科学   32242篇
皮肤病学   2261篇
神经病学   14018篇
特种医学   5321篇
外国民族医学   12篇
外科学   22123篇
综合类   1952篇
现状与发展   1篇
一般理论   171篇
预防医学   12401篇
眼科学   3121篇
药学   10014篇
  2篇
中国医学   213篇
肿瘤学   9678篇
  2023年   587篇
  2022年   1021篇
  2021年   2658篇
  2020年   1576篇
  2019年   2579篇
  2018年   2990篇
  2017年   2238篇
  2016年   2499篇
  2015年   3104篇
  2014年   4354篇
  2013年   6506篇
  2012年   9612篇
  2011年   10122篇
  2010年   5756篇
  2009年   5580篇
  2008年   9603篇
  2007年   10157篇
  2006年   9967篇
  2005年   10289篇
  2004年   9701篇
  2003年   9434篇
  2002年   8918篇
  2001年   1378篇
  2000年   1073篇
  1999年   1438篇
  1998年   1955篇
  1997年   1651篇
  1996年   1349篇
  1995年   1306篇
  1994年   1055篇
  1993年   1098篇
  1992年   858篇
  1991年   784篇
  1990年   745篇
  1989年   675篇
  1988年   630篇
  1987年   583篇
  1986年   594篇
  1985年   705篇
  1984年   868篇
  1983年   879篇
  1982年   1201篇
  1981年   1100篇
  1980年   987篇
  1979年   483篇
  1978年   591篇
  1977年   562篇
  1976年   463篇
  1975年   426篇
  1974年   375篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
6.
Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supplement (epigallocatechin-3-gallate, EGCG) on FAS and Ki-67 levels in prostate tissue. Through a double-blinded, randomized controlled trial with 2 × 2 factorial design, 89 men scheduled for repeat prostate biopsy following an initial negative prostate biopsy were randomized into either FO alone (1.9 g DHA + EPA/day), EGCG alone (600 mg/day), a combination of FO and EGCG, or placebo. We used linear mixed-effects models to test the differences of prostate tissue FAS and Ki-67 by immunohistochemistry between pre- and post-intervention within each group, as well as between treatment groups. Results did not show significant difference among treatment groups in pre-to-post-intervention changes of FAS (P = 0.69) or Ki-67 (P = 0.26). Comparing placebo group with any of the treatment groups, we did not find significant difference in FAS or Ki-67 changes (all P > 0.05). Results indicate FO or EGCG supplementation for a short duration may not be sufficient to produce biologically meaningful changes in FAS or Ki-67 levels in prostate tissue.  相似文献   
7.
8.
9.
10.

Background

Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.

Methods

Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.

Results

Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).

Conclusions

Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号